Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05020028 · ClinicalTrials.gov registry record · Phase 2

Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis

A Phase 2 study of Knee Arthritis, sponsored by NYU Langone Health.

Recruiting
Registry status
Phase 2
Development phase
100
Enrollment target
1
Study location

NCT05020028 is a Phase 2 study of Knee Arthritis that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 127-participant average among 7 other Knee Arthritis trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05020028, a Phase 2 study of Knee Arthritis, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
Phase 2
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if cannabidiol (CBD) orally dissolving tablets (ODTs) can lessen pain, improve function, and improve patient satisfaction in cases of knee osteoarthritis. CBD comes from the cannabis plant and is non-psychoactive (i.e. does not produce a 'high' or altered mental state) as compared to tetrahydrocannabinol (THC), another compound found in cannabis. Researchers are studying different forms of CBD for potential use in treating pain, inflammation, and illnesses.

Conditions Studied

Knee Arthritis

Interventions

  • DRUG Placebo
  • DRUG Cannabidiol (CBD)

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-06-22
Est. Completion 2026-09
Phase Phase 2

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05020028

The ClinicalTrials.gov registry entry for NCT05020028 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 127-participant average among 7 other Knee Arthritis trials with a reported enrollment target (21% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Knee Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05020028 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05020028 about?

NCT05020028 is a clinical study titled "Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis". The purpose of this study is to see if cannabidiol (CBD) orally dissolving tablets (ODTs) can lessen pain, improve function, and improve patient satisfaction in cases of knee osteoarthritis. CBD comes from the cannabis plant and is non-psychoactive (i.e. does not produce a 'high' or altered mental s...

What is the current status of trial NCT05020028?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2022-06-22. Estimated completion is 2026-09.

What conditions does trial NCT05020028 study?

This clinical trial studies the following conditions: Knee Arthritis.

What interventions are being tested in trial NCT05020028?

The interventions under investigation include: Placebo (DRUG), Cannabidiol (CBD) (DRUG).

Who is sponsoring clinical trial NCT05020028?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05020028 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Knee Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Knee Arthritis

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.